リヒン・プラヌスの心代謝併発症 - 横断的比較研究
Mihaela Paula Toader1, Oana Mihaela Condurache Hrițcu1, Cristina Colac Boțoc2
1Discipline of Oral Medicine, Oral Dermatology, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Diagnostics (Basel, Switzerland)
|August 28, 2025
まとめ
2型糖尿病と高血圧のリスクが高くなります. 経口リケーン・プラヌス亜型は,異なる代謝プロファイルを示し,LP患者における代謝スクリーニングの必要性を示しています.
科学分野:
- 皮膚科
- 心臓病科
- 内分泌学
背景:
- 心血管疾患 (CVD) は,世界中で主要な死因です.
- 牛皮病は心臓代謝リスクの要因として知られている.
- リチェン・プランス (LP) は,心臓代謝リスクに関する研究不足の慢性炎症疾患である.
研究 の 目的:
- LP患者および健康な対照群におけるメタボリックシンドローム (MetS) 構成要素の流行および臨床パターンを比較する.
- 系統療法を受けていない患者の内在の炎症的負担を評価する.
- 特定のLPサブタイプが異なる代謝プロファイルを持っているかどうかを調べる.
主な方法:
- 横断的な観察研究では,236人の成人患者 (78人の患者,79人の患者,79人の患者) が参加しました.
- 収集されたデータには,人口統計,臨床的特徴,検査結果が含まれていた.
- LPサブタイプとソーリアーシスの重症度は,検証された指標を用いて評価され,心臓代謝併発症はガイドラインに従って評価された.
主要な成果:
- LP患者は対照群と比較して高血圧 (OR1. 94) と2型糖尿病 (OR3. 09) の確率が高かった.
- LPは,多脂症と比較して,混合多脂症 (OR3. 41) の増加と関連していた.
- 口服用LPサブタイプ,特に侵食性および網状の形態は,心臓代謝リスクの上昇と関連していました.
結論:
- Lichen planus,特に口腔のサブタイプは,ソーリアーシスと同等またはそれ以上の明確な心代謝リスクプロファイルを示しています.
- これらの発見は,LP患者に対する体系的な代謝スクリーニングの重要性を強調しています.
- 総合的な患者管理のために,統合された皮膚および代謝ケアが推奨されます.
さらに関連する動画
関連する概念動画
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
01:21Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31